Alzex Neuropharma

(OTC) TRRI

Current Price$0.00

Market Cap$800

Since IPO (2008)-100%

5 Year-98%

1 Year-99%

1 Month+400%

Alzex Neuropharma Financials at a Glance

Market Cap

$800

Revenue (TTM)

$0.00

Net Income (TTM)

$254.12K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4.99 (High)

Dividend

$0.00

Beta (Volatility)

4.99 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.07

Dividend

$0.00

Beta (Volatility)

4.99 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.07

TRRI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alzex Neuropharma

Industry

Metals and Mining

Sector

Materials

CEO

Robert W. Rosner

Website

trinresinc.com

Headquarters

Las Vegas, NV 89052, US

TRRI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

75%

Return on Assets

-8%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$800.00

Shares Outstanding

1.51M

Volume

Avg. Volume

55.81

Financials (TTM)

Gross Profit

$0.00

Operating Income

$163.49K

EBITDA

$163.49K

Operating Cash Flow

$88.20K

Capital Expenditure

$0.00

Free Cash Flow

$88.20K

Cash & ST Invst.

$1.02K

Total Debt

$91.20K

Alzex Neuropharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$800.00

N/A

Market Cap/Employee

$72.73

N/A

Employees

N/A

Net Income

$85.58K

-99.0%

EBITDA

$83.68K

-804.3%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Net Cash

$116.96K

-29.7%

Accounts Receivable

$6.46K

-51.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$117.12K

+28.4%

Return on Assets

-8.45%

N/A

Return on Invested Capital

74.97%

N/A

Free Cash Flow

$3.59K

+94.0%

Operating Cash Flow

$3.59K

+94.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CNTOCentor Energy, Inc.

CNTOCentor Energy, Inc.$0.00+0.00%

BKSLFBanks Island Gold Ltd.

BKSLFBanks Island Gold Ltd.$0.00+0.00%

ASKEAlaska Pacific Energy Corp.

ASKEAlaska Pacific Energy Corp.$0.00+0.00%

RKTEReflectkote, Inc.

RKTEReflectkote, Inc.$0.00+0.00%

GRENGreensmart Corp

GRENGreensmart Corp$0.00+0.00%

QGRSFQ2 Gold Resources Inc.

QGRSFQ2 Gold Resources Inc.$0.00+0.00%

URPLFNew Klondike Exploration Ltd.

URPLFNew Klondike Exploration Ltd.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.61+0.06%

NOKNokia

NOKNokia$13.64+0.06%

POETPoet Technologies

POETPoet Technologies$13.91+0.27%

IRENIren

IRENIren$59.42-0.03%

RXTRackspace Technology

RXTRackspace Technology$5.13-0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.22+0.01%

ODYSOdysight.ai

ODYSOdysight.ai$5.82+0.30%

Questions About TRRI

What is the current price of Alzex Neuropharma?

Alzex Neuropharma is trading at $0.00 per share.

What is the 52-week range for Alzex Neuropharma?

Over the past 52 weeks, Alzex Neuropharma has traded between $0.00 and $0.07.

How much debt does Alzex Neuropharma have?

As of the most recent reporting period, Alzex Neuropharma reported total debt of $117,124.

How much cash does Alzex Neuropharma have on hand?

Alzex Neuropharma reported $160 in cash and cash equivalents in its most recent financial results.

What is Alzex Neuropharma’s dividend yield?

Alzex Neuropharma does not currently have a dividend yield.

Alzex Neuropharma

Alzex Neuropharma Financials at a Glance

TRRI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alzex Neuropharma

TRRI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alzex Neuropharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TRRI

What is the current price of Alzex Neuropharma?

What is the 52-week range for Alzex Neuropharma?

How much debt does Alzex Neuropharma have?

How much cash does Alzex Neuropharma have on hand?

What is Alzex Neuropharma’s dividend yield?

Premium Investing Services